Abstract: The present invention provides a fused heteroaryl compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal arrhythmia) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

Abstract: A medium conveyance device includes a conveyor configured to convey a medium along a conveyance path, a first sensor configured to detect whether or not the medium is disposed is a detection region in the conveyance path, and a controller configured to control the conveyor to convey the medium in an ejection direction opposite to a feed direction when the conveyor conveys the medium in the feed detection and when the first sensor no longer detects the medium, wherein the controller controls the conveyor to convey the medium in the ejection direction when the conveyor keeps the medium stopped and when the first sensor no longer detects the medium.